Skip to main content

Table 1 The antimicrobial susceptibility testing results of 65 LRE strains

From: Genomic epidemiology reveals multiple mechanisms of linezolid resistance in clinical enterococci in China

Antibiotic

S%

I%

R%

PEN

59/65 (90.8%)

0/65 (0%)

6/65 (9.2%)

AMP

59/65 (90.8%)

0/65 (0%)

6/65 (9.2%)

TGC

65/65 (100%)

0/65 (0%)

0/65 (0%)

ERY

1/65 (1.5%)

4/65 (6.2%)

60/65 (92.3%)

TEC

64/65 (98.5%)

0/65 (0%)

1/65 (1.5%)

VAN

64/65 (98.5%)

0/65 (0%)

1/65 (1.5%)

LEV

9/65 (13.8%)

1/65 (1.5%)

55/65 (84.6%)

FOS

65/65(100%)

0/65 (0%)

0/65 (0%)

NIT

65/65(100%)

0/65 (0%)

0/65 (0%)

TCY

0/65 (0%)

0/65 (0%)

65/65 (100%)

DAP

26/65 (40.0%)

34/65 (52.3%)

5/65 (7.7%)

CHL

0/65 (0%)

4/65 (6.2%)

61/65 (93.8%)

RIF

31/65 (47.7%)

30/65 (46.2%)

4/65 (6.2%)

MI

9/65 (13.8%)

38/65 (58.5%)

18/65 (27.7%)

  1. Note: S, susceptible; I, intermediate; R, resistant; PEN, Penicillin; AMP, Ampicillin; TGC, Tigecycline; ERY, Erythromycin; TEC, Teicoplanin; VAN, Vancomycin; LEV, Levofloxacin; FOS, Fosfomycin; NIT, Nitrofurantoin; TCY, Tetracycline; DAP, Daptomycin; CHL, Chloramphenicol; RIF, Rifampicin; MI, Minocycline